- Home
- CDTX vs CLPT Comparison
CDTX vs CLPT Comparison
Compare CDTX & CLPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDTX
- CLPT
- Stock Information
- Founded
- CDTX 2012
- CLPT 1998
- Country
- CDTX United States
- CLPT United States
- Employees
- CDTX N/A
- CLPT N/A
- Industry
- CDTX Biotechnology: Biological Products (No Diagnostic Substances)
- CLPT Medical/Dental Instruments
- Sector
- CDTX Health Care
- CLPT Health Care
- Exchange
- CDTX Nasdaq
- CLPT Nasdaq
- Market Cap
- CDTX 333.3M
- CLPT 315.7M
- IPO Year
- CDTX 2015
- CLPT N/A
- Fundamental
- Price
- CDTX $47.64
- CLPT $11.69
- Analyst Decision
- CDTX Strong Buy
- CLPT Strong Buy
- Analyst Count
- CDTX 11
- CLPT 3
- Target Price
- CDTX $52.11
- CLPT $27.67
- AVG Volume (30 Days)
- CDTX 1.2M
- CLPT 517.1K
- Earning Date
- CDTX 08-12-2025
- CLPT 08-06-2025
- Dividend Yield
- CDTX N/A
- CLPT N/A
- EPS Growth
- CDTX N/A
- CLPT N/A
- EPS
- CDTX N/A
- CLPT N/A
- Revenue
- CDTX $302,000.00
- CLPT $32,235,999.00
- Revenue This Year
- CDTX N/A
- CLPT $23.97
- Revenue Next Year
- CDTX N/A
- CLPT $27.52
- P/E Ratio
- CDTX N/A
- CLPT N/A
- Revenue Growth
- CDTX N/A
- CLPT 23.22
- 52 Week Low
- CDTX $10.14
- CLPT $5.11
- 52 Week High
- CDTX $56.83
- CLPT $19.22
- Technical
- Relative Strength Index (RSI)
- CDTX 77.41
- CLPT 47.82
- Support Level
- CDTX $45.42
- CLPT $11.19
- Resistance Level
- CDTX $50.48
- CLPT $14.23
- Average True Range (ATR)
- CDTX 3.83
- CLPT 0.69
- MACD
- CDTX 2.31
- CLPT -0.01
- Stochastic Oscillator
- CDTX 74.94
- CLPT 38.10
About CDTX Cidara Therapeutics Inc.
Cidara Therapeutics Inc is developing immunotherapeutics designed to help improve the standard of care for patients facing serious diseases. Its clinical-stage asset is CD388, a DFC intended for influenza prophylaxis. The Company's portfolio comprises new approaches aimed at transforming existing treatment and prevention paradigms, including DFCs from its proprietary Cloudbreak platform targeting oncologic, viral and autoimmune diseases.
About CLPT ClearPoint Neuro Inc.
ClearPoint Neuro Inc is a medical device company based in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain and heart under direct, intra-procedural magnetic resonance imaging (MRI) guidance. The company's ClearPoint system, which is in commercial use, is used to perform minimally invasive surgical procedures in the brain. The company's products include the ClearPoint system, ClearPoint Services, ClearPoint Disposables, ClearPoint Software, and ClearPoint Therapeutic Solutions.